Summary
- Current Price
- As of today, XERS price is $6.23, down -1.74% on
- Current Price All-Time High
- XERS price is currently -77.73% below its historical high of $27.98 set on
- Market Cap
- XERS current market cap is $1B, up +56.17% over the past 365 days
- PE Ratio
- XERS PE ratio is unknown
- Revenue
- XERS current annual revenue is $291.85M, up +43.72% year-over-year
- Next Earnings
- The next earnings release for XERS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Xeris Biopharma Holdings, Inc. |
| Ticker | NASDAQ: XERS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | xerispharma.com |
| Employees | 394 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $6.23 | |
| Price, 1D Change | -1.74% | |
| $1B | ||
| - | ||
| - | ||
| 1.01 | ||
| $292M | ||
| Revenue, 1Y Change | +43.72% | |
| $0.00 | ||
| EPS, 1Y Change | +100.86% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| EPS Estimate | N/A | $0.16 |
| EPS Est. Change | N/A | +4,890.63% |
| $291.85M | ||
| Revenue Estimate | N/A | $383.34M |
| Revenue Est. Change | N/A | +31.35% |
| Current Price | $6.23 | |
| Price Target | - | $10.00 |
| Price Tgt. Change | - | +60.51% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.25 | -$0.37 | -52.49% | |
| $0.06 | $0.00 | -94.92% | |
| $0.16 | N/A | +4,890.63% | |
| $0.39 | N/A | +12,109.38% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $201.51M | $203.07M | +0.77% | |
| $292.00M | $291.85M | -0.05% | |
| $383.34M | N/A | +31.35% | |
| $471.48M | N/A | +61.55% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $6.23 | |
| $7.07 | ||
| SMA 200 vs Price | +13.45% | |
| $5.92 | ||
| SMA 50 vs Price | -4.91% | |
| 1.01 | ||
| $0.23 | ||
| 55.02 | ||
| 26.16% | ||
| 58.30% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $291.85M | ||
| $0.00 | ||
| $238.43M | ||
| 81.70% | ||
| $24.90M | ||
| 8.53% | ||
| $554.00K | ||
| 0.19% | ||
| $37.59M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 18.85 | ||
| 2.19 | ||
| 1.57 | ||
| - | ||
| 7 | ||
| 0.66 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 3.69 | ||
| 78.56 | ||
| 32.52 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $13.69M | ||
| $111.04M | ||
| $392.94M | ||
| $240.31M | ||
| $379.25M | ||
| $109.57M | ||
| $258.10M | ||
| $6.23M | ||
| $3.08M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $291.29M | ||
| $213.54M | ||
| $53.41M | ||
| $0.00 | ||
| $12.69M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $28.63M | ||
| -$696.00K | ||
| $11.39M | ||
| $696.00K | ||
| $27.93M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Barclays | ||
| Piper Sandler | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| Leerink Partners | → | |
| Oppenheimer | → |
Analyst sentiment
Institutional ownership
Screeners with XERS
FAQ
What is the ticker symbol for Xeris Biopharma Holdings, Inc.?
The ticker symbol for Xeris Biopharma Holdings, Inc. is NASDAQ:XERS
Does Xeris Biopharma Holdings, Inc. pay dividends?
No, Xeris Biopharma Holdings, Inc. does not pay dividends
What sector is Xeris Biopharma Holdings, Inc. in?
Xeris Biopharma Holdings, Inc. is in the Healthcare sector
What industry is Xeris Biopharma Holdings, Inc. in?
Xeris Biopharma Holdings, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Xeris Biopharma Holdings, Inc. based in?
Xeris Biopharma Holdings, Inc. is headquartered in United States
When did Xeris Biopharma Holdings, Inc. go public?
Xeris Biopharma Holdings, Inc. initial public offering (IPO) was on June 21, 2018
Is Xeris Biopharma Holdings, Inc. in the S&P 500?
No, Xeris Biopharma Holdings, Inc. is not included in the S&P 500 index
Is Xeris Biopharma Holdings, Inc. in the NASDAQ 100?
No, Xeris Biopharma Holdings, Inc. is not included in the NASDAQ 100 index
Is Xeris Biopharma Holdings, Inc. in the Dow Jones?
No, Xeris Biopharma Holdings, Inc. is not included in the Dow Jones index
When was Xeris Biopharma Holdings, Inc. last earnings report?
Xeris Biopharma Holdings, Inc.'s most recent earnings report was on March 2, 2026
When does Xeris Biopharma Holdings, Inc. report earnings?
The next expected earnings date for Xeris Biopharma Holdings, Inc. is May 7, 2026
Data Sources & References
- XERS Official Website www.xerispharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1867096/000186709626000016/0001867096-26-000016-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1867096/000186709626000016/0001867096-26-000016-index.htm
- XERS Profile on Yahoo Finance finance.yahoo.com/quote/XERS
- XERS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/xers